Page last updated: 2024-08-21

hesperidin and Retinal Diseases

hesperidin has been researched along with Retinal Diseases in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Fujita, K; Ge, S; Himori, N; Maekawa, S; Nakazawa, T; Nishiguchi, KM; Ohno-Oishi, M; Omodaka, K; Ozawa, M; Sato, K; Sato, T; Shiga, Y; Yabana, T; Yasuda, M1
Li, Y; Liu, H; Xin, X1
Daigaku, R; Fujita, K; Maekawa, S; Maruyama, K; Moritoh, S; Murayama, N; Nakazawa, T; Nishiguchi, KM; Omodaka, K; Sato, K; Shiga, Y; Tawarayama, H; Yabana, T1
Caldwell, RB; Kimura, S; Kobayashi, H; Matsumoto, C; Nagaoka, T; Narayanan, SP; Ono, S; Shimouchi, A; Takumi, H; Tamai, T; Yokota, H; Yoshida, A1

Other Studies

4 other study(ies) available for hesperidin and Retinal Diseases

ArticleYear
CHOP deletion and anti-neuroinflammation treatment with hesperidin synergistically attenuate NMDA retinal injury in mice.
    Experimental eye research, 2021, Volume: 213

    Topics: Animals; Blotting, Western; Calcium-Binding Proteins; Cytokines; Disease Models, Animal; Drug Synergism; Gene Deletion; Hesperidin; Immunohistochemistry; In Situ Nick-End Labeling; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microfilament Proteins; Microglia; N-Methylaspartate; Neuroprotection; NF-kappa B; Oxidative Stress; Real-Time Polymerase Chain Reaction; Retinal Diseases; Retinal Ganglion Cells; Transcription Factor CHOP

2021
Hesperidin ameliorates hypobaric hypoxia-induced retinal impairment through activation of Nrf2/HO-1 pathway and inhibition of apoptosis.
    Scientific reports, 2020, 11-10, Volume: 10, Issue:1

    Topics: Animals; Apoptosis; Blotting, Western; Heme Oxygenase-1; Hesperidin; Hypoxia; Immunohistochemistry; In Situ Nick-End Labeling; Male; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Retina; Retinal Diseases; RNA, Messenger

2020
The neuroprotective effect of hesperidin in NMDA-induced retinal injury acts by suppressing oxidative stress and excessive calpain activation.
    Scientific reports, 2017, 07-31, Volume: 7, Issue:1

    Topics: Animals; Apoptosis; Calpain; Cells, Cultured; Disease Models, Animal; Evoked Potentials, Visual; Hesperidin; Male; Mice; N-Methylaspartate; Neuroprotective Agents; Oxidative Stress; Retina; Retinal Diseases; Retinal Ganglion Cells; Treatment Outcome; Tumor Necrosis Factor-alpha

2017
Neuroprotective effect of water-dispersible hesperetin in retinal ischemia reperfusion injury.
    Japanese journal of ophthalmology, 2016, Volume: 60, Issue:1

    Topics: Animals; Biomarkers; Blotting, Western; Disease Models, Animal; Hesperidin; Immunohistochemistry; In Situ Nick-End Labeling; Injections, Intraperitoneal; Interleukin-1beta; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Mitogen-Activated Protein Kinases; Neuroprotective Agents; Oxidative Stress; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Reperfusion Injury; Retinal Diseases; Retinal Ganglion Cells; Retinal Vessels; Solubility; Water

2016